Jim Simons Pasithea Therapeutics Corp. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$0.28 - $0.48 $458 - $785
1,636 Added 5.3%
32,500 $12,000
Q3 2023

Nov 14, 2023
SELL
$0.44 - $0.63 $1,699 - $2,433
-3,863 Reduced 11.12%
30,864 $15,000
Q2 2023

Aug 11, 2023
BUY
$0.31 - $0.5 $1,155 - $1,863
3,727 Added 12.02%
34,727 $17,000
Q1 2023

May 12, 2023
BUY
$0.38 - $0.73 $11,780 - $22,630
31,000 New
31,000 $12,000

About Pasithea Therapeutics Corp.

KTTA Quotes by TradingView
  • Ticker KTTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,398,700
  • Market Cap $74.7M
  • Description
  • Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...
More about KTTA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email